Patrick Muck (Good Samaritan Hospital, Cincinnati, USA) is joined in the CX Studio by David Dexter (Sentara Vascular Specialists, Norfolk, USA), Steven Abramowitz (MedStar Health, Washington DC, USA) and Stavros Konstantinides (University of Mainz, Mainz, Germany) to talk about the fast-developing pulmonary embolism (PE) treatment landscape. They discuss the slew of data arriving in the space, from the HI-PEITHO, STORM-PE and STRIKE-PE trials, to PEERLESS and the upcoming PEERLESS 2.











